Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
14.34
+0.15 (1.06%)
At close: Dec 20, 2024, 4:00 PM
14.33
-0.01 (-0.07%)
After-hours: Dec 20, 2024, 6:29 PM EST
Progyny Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Progyny stock have an average target of 19.17, with a low estimate of 17 and a high estimate of 24. The average target predicts an increase of 33.68% from the current stock price of 14.34.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Progyny stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 1 | 2 | 2 | 2 | 2 |
| Buy | 4 | 3 | 2 | 2 | 2 | 1 |
| Hold | 1 | 4 | 5 | 5 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy → Hold Downgrades $22 → $17 | Buy → Hold | Downgrades | $22 → $17 | +18.55% | Dec 2, 2024 |
| Barclays | Barclays | Buy Maintains $30 → $17 | Buy | Maintains | $30 → $17 | +18.55% | Nov 14, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $22 → $21 | Strong Buy | Maintains | $22 → $21 | +46.44% | Nov 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | +18.55% | Nov 13, 2024 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $26 → $19 | Strong Buy → Hold | Downgrades | $26 → $19 | +32.50% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
1.17B
from 1.09B
Increased by 7.20%
Revenue Next Year
1.18B
from 1.17B
Increased by 1.20%
EPS This Year
0.56
from 0.62
Decreased by -9.63%
EPS Next Year
0.63
from 0.56
Increased by 13.23%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.2B | 1.3B | 1.4B | |||
| Avg | 1.2B | 1.2B | 1.3B | |||
| Low | 1.1B | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 10.7% | 7.1% | 19.7% | |||
| Avg | 7.2% | 1.2% | 11.0% | |||
| Low | 2.4% | -6.5% | -1.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 0.67 | 1.02 | 1.32 | |||
| Avg | 0.56 | 0.63 | 0.91 | |||
| Low | 0.49 | 0.51 | 0.60 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 8.4% | 81.8% | 108.5% | |||
| Avg | -9.6% | 13.2% | 43.5% | |||
| Low | -21.0% | -9.4% | -4.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.